Amgen invests £50 million ($66 Million) in Oxford Nanopore Technologies
Amgen and Oxford Nanopore Technologies announced Amgen's equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology. October 18, 2018